Vetoquinol SA Logo

Vetoquinol SA

Develops and markets veterinary medicines for companion animals and livestock.

VETO | PA

Overview

Corporate Details

ISIN(s):
FR0004186856
LEI:
969500YP0AETQIK48R39
Country:
France
Address:
Village, 70200 MAGNY-VERNOIS

Description

Vetoquinol SA is a global animal health company that researches, develops, produces, and markets veterinary medicines and non-medicinal products. The company provides solutions for both companion animals (cats and dogs) and livestock (cattle and pigs). Its product portfolio addresses a wide range of therapeutic areas, including mobility, dermatology, anti-parasitics, antibiotics, internal medicine, and behavior management. Founded in 1933, the independent, family-owned business focuses on innovation and maintaining a close relationship with veterinary professionals to support animal well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-05-25 17:45
Informations privilégiées / Autres communiqués
French PDF 474.5 KB
2023-05-25 17:45
Inside Information / Other news releases
English PDF 468.3 KB
2023-05-02 17:45
Inside Information / Other news releases
English PDF 503.1 KB
2023-05-02 17:45
Informations privilégiées / Autres communiqués
French PDF 507.7 KB
2023-04-24 17:45
Informations privilégiées / Autres communiqués
French PDF 504.0 KB
2023-04-24 17:45
Inside Information / Other news releases
English PDF 496.5 KB
2023-04-19 17:45
Quarterly financial reporting / First quarter financial report
English PDF 695.9 KB
2023-04-19 17:45
Information financière trimestrielle / Information financière du premier trimes…
French PDF 702.5 KB
2023-04-13 17:45
Annual financial and audit reports / Terms of availability of the annual financ…
English PDF 471.6 KB
2023-04-13 17:45
Rapports financiers et d'audit annuels / Rapport financier annuel
French PDF 5.9 MB
2023-04-13 09:17
DEPOT DEU VETOQUINOL
French ZIP 25.5 MB
2023-04-13 09:17
DEPOT DEU VETOQUINOL
French ZIP 25.5 MB
2023-03-27 17:45
Informations privilégiées / Autres communiqués
French PDF 494.7 KB
2023-03-27 17:45
Inside Information / Other news releases
English PDF 493.9 KB
2023-03-23 08:00
Inside Information / News release on accounts, results
English PDF 758.5 KB

Automate Your Workflow. Get a real-time feed of all Vetoquinol SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vetoquinol SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vetoquinol SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-25 N/A Other Sell 4,000 399,600.00 EUR
2024-07-25 N/A Other Buy 4,000 399,600.00 EUR
2024-03-21 N/A Other Sell 3,500 346,500.00 EUR
2024-03-21 N/A Other Buy 3,500 346,500.00 EUR
2024-01-03 N/A Other Buy 1,800 182,880.00 EUR
2023-11-16 N/A Other Buy 1,000 87,500.00 EUR
2023-11-13 N/A Other Sell 1,000 87,500.00 EUR
2023-09-08 N/A Other Buy 400 33,960.00 EUR

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.